Revvity
Revvity, Inc. (NYSE: RVTY) is a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development and diagnosis to cure. The company maintains headquarters in Waltham, Massachusetts and operates a global presence across more than 160… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Revvity does
In the company’s own words
Revvity, Inc. (NYSE: RVTY) is a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development and diagnosis to cure. The company maintains headquarters in Waltham, Massachusetts and operates a global presence across more than 160 countries with approximately 11,000 employees worldwide, roughly 80 percent of whom are based outside the United States. The company's common stock is listed on the S&P 500 Index.
Revvity operates through two primary business segments: Life Sciences and Diagnostics. The Life Sciences segment provides a comprehensive portfolio of technologies, products, software and services that help life sciences researchers understand diseases and develop treatments. This division offers reagents, instruments, software and licensing technologies across cell, gene and protein research applications, serving pharmaceutical, biotech and contract research organizations as well as academic and government institutions. The Diagnostics segment focuses on reproductive health, immunodiagnostics and emerging market diagnostics, providing instruments, reagents, assay platforms and software to hospitals, medical labs and clinicians for early detection of common and rare conditions and infectious disease testing.
The company's extensive product portfolio includes recognized brands such as BioLegend, Dharmacon, IVIS, Opera Phenix, Operetta, DELFIA, Vanadis and T-SPOT, among numerous others. Revvity maintains approximately 2,000 sales and service representatives operating across roughly 40 countries, with distribution networks in regions where direct sales presence is not maintained.
The company's strategy emphasizes developing innovative products and services in high-growth markets through both internal research and development investment and strategic acquisitions. Key strategic priorities include strengthening market positions through expanded global offerings, attracting and retaining talented employees, accelerating transformational innovation through collaborations, augmenting growth through strategic acquisitions and licensing, advancing artificial intelligence applications, improving operational excellence and maintaining disciplined capital allocation. Revvity competes on the basis of service level, price, technological innovation, operational efficiency, product differentiation, product availability, quality and reliability. The company maintains its website at http://www.revvity.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Medical Instruments
- Headquarters
- WALTHAM, MA
- Fiscal year end
- December
- CIK
- 31791
- SIC
- 3826
Financial performance, year by year
Fiscal 2012–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Revvity — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Revvity’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Revvity’s bonds, as funds hold them
Funds report holding 5 issues of Revvity’s debt, $407.98M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 2.73%, maturing 2028 to 2051.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Revvity and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Revvity's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Revvity's last four quarterly filings that the numbers alone won't show?”